Active Ingredient(s): Dihydroergotamine Mesylate
FDA Approved: * September 2, 2021
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trudhesa Overview

Dihydroergotamine (DHE), sold under the brand names D.H.E. 45 and Migranal among others, is an ergot alkaloid used to treat migraines.[1] It is a derivative of ergotamine. It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan. Nausea is a common side effect.[2] It has similar actions to the triptans, acting as an agonist to the serotonin receptors and causing vasoconstriction of the intracranial blood vessels, but a...

Read more Trudhesa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Trudhesa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dihydroergotamine Mesylate
  • Injection: 1mg/ml
  • Spray: 4mg/ml
  • Spray, Metered: 0.5mg/inh, 0.5mg/spray, 0.725mg/spray, 4mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Dihydroergotamine Mesylate or a similar ingredient: (4 results)